Invion will prevail, page-2

  1. 1,206 Posts.
    lightbulb Created with Sketch. 116
    Eirexpat, the marketing strategy is pretty clear. Ferghana partners to table the best deal with a big respiratory pharma ( and that's not Pfizer, they sold their respiratory arm). Pharma want IP certainty and patent protection that won't be challenged for the investment they will make. Directors interests are aligned with ours, Dr Glass and Dr Collier are the 6th largest individual shareholders. They won't be selling anything based on charts over the years, it will be the science plus iron clad patent protection.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.7¢
Change
0.003(3.19%)
Mkt cap ! $8.232M
Open High Low Value Volume
10.0¢ 10.0¢ 9.7¢ $3.425K 34.93K

Buyers (Bids)

No. Vol. Price($)
1 5200 9.7¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 244080 3
View Market Depth
Last trade - 15.55pm 25/07/2025 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.